Branning Todd P.
Related Filers (3)
- NeuBase Therapeutics, Inc. (6)
- Amneal Pharmaceuticals, Inc. (5)
- Phathom Pharmaceuticals, Inc. (3)
- Show More ...
Ownership (14)
4
Friday, 3/17/2023
NeuBase Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/4/2022
NeuBase Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/21/2022
NeuBase Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/18/2022
NeuBase Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/10/2022
NeuBase Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 1/10/2022
NeuBase Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 1/29/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 7/13/2020
Phathom Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 7/13/2020
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/2/2020
Amneal Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/23/2020
Amneal Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/14/2019
Amneal Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/24/2019
Amneal Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/23/2019
Amneal Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities